Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 3
This trial is looking at adding durvalumab to chemotherapy after surgery to remove non small cell lung cancer (NSCLC).
It is also looking at measuring small amounts of cancer cells that may be in the bloodstream after surgery.
It is for people who have stage 2 or stage 3 NSCLC. That is early stage cancer or cancer that has grown into nearby tissues or .
Recruitment start: 20 July 2021
Recruitment end: 20 May 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gary Middleton
AstraZeneca
Last reviewed: 25 May 2022
CRUK internal database number: 17682
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
